BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 19020415)

  • 1. Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal.
    Hodgson SR; Hofford RS; Norris CJ; Eitan S
    Behav Pharmacol; 2008 Dec; 19(8):805-11. PubMed ID: 19020415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased elevated plus maze open-arm time in mice during spontaneous morphine withdrawal.
    Buckman SG; Hodgson SR; Hofford RS; Eitan S
    Behav Brain Res; 2009 Feb; 197(2):454-6. PubMed ID: 18955087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiety profile in morphine-dependent and withdrawn rats: effect of voluntary exercise.
    Miladi-Gorji H; Rashidy-Pour A; Fathollahi Y
    Physiol Behav; 2012 Jan; 105(2):195-202. PubMed ID: 21871908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
    Pinelli A; Cighetti G; Trivulzio S
    Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The discriminative stimulus properties of naloxone during dissociative learning in a Y maze in morphine-dependent rats].
    Bespalov AIu; Medvedev IO; Dravolina OA; Zvartau EE
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1999; 49(1):96-105. PubMed ID: 10330710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogen-rich saline attenuates anxiety-like behaviors in morphine-withdrawn mice.
    Wen D; Zhao P; Hui R; Wang J; Shen Q; Gong M; Guo H; Cong B; Ma C
    Neuropharmacology; 2017 May; 118():199-208. PubMed ID: 28359771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice.
    Li T; Hou Y; Cao W; Yan CX; Chen T; Li SB
    Neurosci Lett; 2010 Jan; 468(3):348-52. PubMed ID: 19922770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective mGlu5 receptor antagonist MTEP attenuates naloxone-induced morphine withdrawal symptoms.
    Pałucha A; Brański P; Pilc A
    Pol J Pharmacol; 2004; 56(6):863-6. PubMed ID: 15662102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baclofen prevents the elevated plus maze behavior and BDNF expression during naloxone precipitated morphine withdrawal in male and female mice.
    Pedrón VT; Varani AP; Balerio GN
    Synapse; 2016 May; 70(5):187-97. PubMed ID: 26789010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obestatin prevents analgesic tolerance to morphine and reverses the effects of mild morphine withdrawal in mice.
    Lipták N; Dochnal R; Csabafi K; Szakács J; Szabó G
    Regul Pept; 2013 Sep; 186():77-82. PubMed ID: 23891980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dansyl-PQRamide, a putative antagonist of NPFF receptors, reduces anxiety-like behavior of ethanol withdrawal in a plus-maze test in rats.
    Kotlinska J; Pachuta A; Bochenski M; Silberring J
    Peptides; 2009 Jun; 30(6):1165-72. PubMed ID: 19463751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiogenic-like effects of spontaneous and naloxone-precipitated opiate withdrawal in the elevated plus-maze.
    Schulteis G; Yackey M; Risbrough V; Koob GF
    Pharmacol Biochem Behav; 1998 Jul; 60(3):727-31. PubMed ID: 9678657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of pituitary adenylate cyclase-activating polypeptide on elevated plus maze behavior and hypothermia induced by morphine withdrawal.
    Lipták N; Dochnal R; Babits A; Csabafi K; Szakács J; Tóth G; Szabó G
    Neuropeptides; 2012 Feb; 46(1):11-7. PubMed ID: 22226680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine withdrawal increases intrinsic excitability of oxytocin neurons in morphine-dependent rats.
    Brown CH; Stern JE; Jackson KL; Bull PM; Leng G; Russell JA
    Eur J Neurosci; 2005 Jan; 21(2):501-12. PubMed ID: 15673449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of sweet tasting solutions on opioid withdrawal.
    Jain R; Mukherjee K; Singh R
    Brain Res Bull; 2004 Dec; 64(4):319-22. PubMed ID: 15561466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is withdrawal hyperalgesia in morphine-dependent mice a direct effect of a low concentration of the residual drug?
    Rubovitch V; Pick CG; Sarne Y
    Addict Biol; 2009 Sep; 14(4):438-46. PubMed ID: 19489750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine withdrawal-induced c-fos expression in the heart: a peripheral mechanism.
    González-Cuello A; Milanés MV; Castells MT; Laorden ML
    Eur J Pharmacol; 2004 Mar; 487(1-3):117-24. PubMed ID: 15033383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressive effects of dichloromethane fraction from the Areca catechu nut on naloxone-precipitated morphine withdrawal in mice.
    Kumarnsit E; Keawpradub N; Vongvatcharanon U; Sawangjaroen K; Govitrapong P
    Fitoterapia; 2005 Sep; 76(6):534-9. PubMed ID: 15993008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of GABA-positive agents on the formation of morphine dependence and on the manifestations of a withdrawal syndrome].
    Belozertseva IV; Andreev BV
    Eksp Klin Farmakol; 2000; 63(1):19-23. PubMed ID: 10763104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.